Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
60835-71-4
110178-35-3
79808-16-5
1049787-84-9
50963-77-4
65673-48-5
55109-26-7 | pentamethylcyclopropane-1-carboxylic acid | AA01BNA5 | MFCD20641174
2024538-64-3 | 6-chloropyrazolo[1,5-a]pyrimidine | AA01BPIO | MFCD30500359
1557482-13-9 | 2-methyl-2H,4H,6H,7H-thiopyrano[4,3-c]pyrazole-3-carbaldehyde | AA01BQZL | MFCD30723979
1156307-10-6 | 3-(5-Fluoro-2-nitrophenyl)propanoic acid | AA01BR3A | MFCD12190909
1368920-29-9 | 3,3-dimethoxybutan-1-amine | AA01BRGA | MFCD21876654
2060042-31-9 | (4-cyclohexylphenyl)methanesulfonamide | AA01BRKS | MFCD30535821
2060042-17-1 | acetic acid, tert-butyl N-(1-carbamimidoylcyclobutyl)carbamate | AA01BRQL | MFCD30535883
347194-01-8 | 3-(Pyridin-2-ylsulfanyl)propan-1-ol | AA01BRUX | MFCD12187012
90484-52-9 | Methyl 2-bromo-4-formylbenzoate | AA01BRZ4 | MFCD26863464
2059935-66-7 | 2,2-dimethyl-3-[4-(trifluoromethyl)phenyl]pyrrolidine hydrochloride | AA01BS3T | MFCD30536074